Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107531003 | 10753100 | 3 | F | 2016 | 20160823 | 20150130 | 20160826 | EXP | US-PFIZER INC-2015032521 | PFIZER | 84.00 | YR | F | Y | 60.31000 | KG | 20160826 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107531003 | 10753100 | 1 | PS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 20 MG, 2X/DAY | Y | 21845 | 20 | MG | FILM-COATED TABLET | BID | |||||
| 107531003 | 10753100 | 2 | C | ASPIRIN ADULT LOW | 2 | 81 MG, 1X/DAY | 0 | 81 | MG | TABLET | QD | ||||||||
| 107531003 | 10753100 | 3 | C | RESTORIL | TEMAZEPAM | 1 | 30 MG, 1 CAPSULE AT BED TIME AS NEEDED ONCE A DAY | 0 | 30 | MG | CAPSULE | QD | |||||||
| 107531003 | 10753100 | 4 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | 12.5 MG, 2X/DAY | 0 | 12.5 | MG | TABLET | BID | |||||||
| 107531003 | 10753100 | 5 | C | LASIX | FUROSEMIDE | 1 | 40 MG, 1X/DAY | 0 | 40 | MG | TABLET | QD | |||||||
| 107531003 | 10753100 | 6 | C | MUCINEX | GUAIFENESIN | 1 | 600 MG TABLET EXTENDED RELEASE 12 HOURS 1 TABLET AS NEEDED EVERY 12 HOURS | 0 | 600 | MG | MODIFIED-RELEASE TABLET | ||||||||
| 107531003 | 10753100 | 7 | C | Potassium Bicarb-citric acid | 2 | 10 MEQ, 1X/DAY | 0 | 10 | MEQ | EFFERVESCENT TABLET | QD | ||||||||
| 107531003 | 10753100 | 8 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 7.5-325 MG 1 TABLET AS NEEDED EVERY 6 HOURS AS NEEDED (PRN) FOR PAIN | 0 | 1 | DF | TABLET | ||||||||
| 107531003 | 10753100 | 9 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | 500 MG, 1 CAPSULE AS NEEDED ONCE A DAY | 0 | 500 | MG | CAPSULE | ||||||||
| 107531003 | 10753100 | 10 | C | TEMAZEPAM. | TEMAZEPAM | 1 | 15 MG 1 CAPSULE AS NEEDED, AT BED TIME; ONCE A DAY | 0 | 15 | MG | CAPSULE | ||||||||
| 107531003 | 10753100 | 11 | C | JAKAFI | RUXOLITINIB | 1 | 15 MG, DAILY | 0 | 15 | MG | TABLET | ||||||||
| 107531003 | 10753100 | 12 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 40 MG TABLET ONCE A DAY | 0 | 40 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107531003 | 10753100 | 1 | Pulmonary hypertension |
| 107531003 | 10753100 | 8 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107531003 | 10753100 | HO |
| 107531003 | 10753100 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107531003 | 10753100 | Dyspnoea | |
| 107531003 | 10753100 | Fluid retention | |
| 107531003 | 10753100 | Productive cough | |
| 107531003 | 10753100 | Urinary tract infection | |
| 107531003 | 10753100 | Weight fluctuation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |